SCHEMBL5199273

SCHEMBL5199273

Cc1cccc(CC(=O)c2cccc(Br)c2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.55
TSHR P16473 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
PARP1 P09874 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
ALDH1A1 P00352 3/20 0.43
GLA P06280 1/20 0.43
RAB9A P51151 4/20 0.42
MAPT P10636 1/20 0.42
RECQL P46063 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PLAU P00749 1/20 0.42
NPC1 O15118 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MGAM O43451 1/20 0.41
AMY1A P0DUB6 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5199837 0.87 TSHR (0.48) GRM5TSHRNPSR1PARP1L3MBTL1
SCHEMBL14592085 0.83 MEN1 (0.48) GRM5L3MBTL1ALDH1A1GLARAB9A
SCHEMBL5943286 0.82 PARP1 (0.44) GRM5TSHRNPSR1PARP1L3MBTL1
SCHEMBL5907456 0.82 ALDH1A1 (0.37) GRM5TSHRALDH1A1RAB9ANPC1
SCHEMBL5200109 0.81 PIM1 (0.40) GRM5ALDH1A1RAB9ANPC1MEN1
SCHEMBL4428289 0.79 TDP1 (0.47) GRM5TSHRNPSR1PARP1L3MBTL1
SCHEMBL6177854 0.76 NPC1 (0.57) L3MBTL1ALDH1A1RAB9AMAPTRECQL
SCHEMBL12118456 0.76 GRM5 (0.43) GRM5TSHRNPSR1RXFP1ALDH1A1
SCHEMBL6179968 0.75 MAPT (0.46) NPSR1ALDH1A1RAB9AMAPTNPC1
Bromide SCHEMBL1312942 0.75 GRM5 (0.42) GRM5TSHRNPSR1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 GRM5 3769/4885TSHR 556/4885NPSR1 1454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.